Clinical Trials on Hepatitis D in Spain

Total 297 results

Gilead Sciences

Recruiting

Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

Chronic Hepatitis D Infection

Austria, Spain, France, Germany, Romania
Janssen Research & Development, LLC

Active, not recruiting

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus (REEF-D)

Hepatitis D, Chronic

France, Taiwan, Italy, Germany, Japan, Spain, Russian Federation, Turkey, United Kingdom, Australia, Sweden, United States, New Zealand, China, Brazil
HepNet Study House, German Liverfoundation
Hannover Medical School; German Center for Infection Research

Completed

The Hepatitis Delta International Network (HDIN)

Hepatitis D

Germany, Austria, Belgium, Brazil, Georgia, Greece, Italy, Moldova, Republic of, Pakistan, Romania, Spain, Vietnam
Eiger BioPharmaceuticals

Active, not recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV (LIMT-2)

Hepatitis Delta Virus

United States, France, Belgium, Spain, Italy, Turkey, Bulgaria, Germany, Israel, Romania, Georgia, Moldova, Republic of
Eiger BioPharmaceuticals

Completed

Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a (D-LIVR)

Hepatitis Delta Virus

United States, Belgium, Spain, Greece, Canada, Italy, Romania, Germany, Israel, Bulgaria, Taiwan, Turkey, Pakistan, Sweden, Ukraine, New Zealand, Russian Federation, United Kingdom, Moldova, Republic of, France, Mongolia, Switzerland
Hospital Universitario Ramon y Cajal

Terminated

Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis (RIBACIR)

Chronic Hepatitis C

Spain
Parc de Salut Mar

Completed

Multidisciplinary Support Program in Chronic Hepatitis C

Hepatitis C, Chronic

Spain
Hospital Clinic of Barcelona

Unknown

Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis

Autoimmune Hepatitis

Spain
Hospital Carlos III, Madrid

Completed

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies (PILOT-NR)

HIV Infections | Chronic Hepatitis C

Spain
Fundacion Clinic per a la Recerca Biomédica

Unknown

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients (EARLY-HEP-C)

Hepatitis C | HIV

Spain
Fundación Pública Andaluza para la gestión de la...

Completed

Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals (Hepatitis)

Hepatitis C, Chronic

Spain
Valme University Hospital
Hospital General Universitario Elche; Hospital del SAS de Jerez; Clinica Universidad... and other collaborators

Completed

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions (FPSMON201401)

Chronic Hepatitis C Infection

Spain
Fundacion SEIMC-GESIDA

Withdrawn

A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A (C-RESCUE)

HCV

Spain
Fundación Pública Andaluza para la gestión de la...

Completed

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4 (OPTIM)

Hepatitis C, Chronic

Spain
Novartis Pharmaceuticals

Completed

Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine (EBEREST)

Hepatitis B, Chronic

Spain
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks (3D8)

Hepatitis C Infection

Spain
Anna Cruceta

Completed

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin (BOC-HIV)

HIV Infections | Hepatitis C | COINFECTION

Spain
Sociedad Andaluza de Enfermedades Infecciosas

Completed

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients (SAEI_IFN_1)

HIV Infections | Hepatitis C, Chronic

Spain
Corporacion Parc Tauli

Completed

Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.

Liver Disease Chronic | Hepatitis B Virus

Spain
Hospital Universitari Vall d'Hebron Research Institute

Completed

Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) (SPLEEN-C)

Cirrhosis | Chronic Hepatitis C | Portal Hypertension

Spain
Hospital Universitario Infanta Leonor

Completed

Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid ((UMC))

HIV Infections | Drug Use | HCV Infection | HBV (Hepatitis B Virus) | Viral Hepatitis

Spain
Hospital Universitari Vall d'Hebron Research Institute

Terminated

Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.

Hepatitis E

Spain
Hospital Clinic of Barcelona

Completed

Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Liver Transplantation | Hepatitis C Virus Infection

Spain
Hospital Clinic of Barcelona
University of Padova; Hospital Vall d'Hebron

Unknown

HBV Vaccine in Anti-core Positive Donors After LT

Hepatitis B Reactivation

Spain
Valme University Hospital
University of Seville

Unknown

Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance (TRITAL)

Hepatitis C

Spain
Bristol-Myers Squibb

Terminated

Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection

Hepatitis C | Chronic Hepatitis

Australia, Spain
Hospital Universitario de Valme
Instituto de Salud Carlos III

Unknown

Prediction of Liver-related Outcomes After HCV Cure

Hepatocellular Carcinoma | Hepatitis C, Chronic | Hepatic Decompensation | Sustained Virological Response | Direct-acting Antivirals

Spain
Hospital Vall d'Hebron

Completed

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Hepatitis C Recurrence After Liver Transplant

Spain
Jose L. Casado

Recruiting

Impact of Hypovitaminosis D on Bone Disease in HIV Infected Patients (PuraVIHta)

Hypovitaminosis D

Spain
Instituto Grifols, S.A.

Completed

Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation

Hepatitis B, Chronic

Spain
Instituto de Investigación Marqués de Valdecilla
Ministerio de Economía y Competitividad, Spain

Unknown

Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC) (CICHepC)

Hepatitis C

Spain
Hospital Clinic of Barcelona
Schering-Plough

Completed

Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.

Hepatitis C

Spain
Valme University Hospital
Hospital Universitario Virgen Macarena; Hospital Universitario Reina Sofia... and other collaborators

Completed

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Hepatitis C, Chronic | Hepatitis B, Chronic | Human Immunodeficiency Virus

Spain
Instituto de Investigación Marqués de Valdecilla

Completed

Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C) (JAILFREE-C)

Hepatitis C

Spain
Fundacion IMIM

Completed

ADHEPTA Study: Adherence Questionnaire in Hepatitis C (ADHEPTA)

HIV Infection | Hepatitis C, Chronic

Spain
Hospital Universitari Vall d'Hebron Research Institute
Germans Trias i Pujol Hospital; Hospital del Mar; Hospital de Sant Pau

Unknown

Effects of Rifaximin in Patients With Acute Alcoholic Hepatitis (RIFA-AAH)

Alcoholic Hepatitis

Spain
Hospitales Universitarios Virgen del Rocío
Bristol-Myers Squibb

Completed

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

HIV Infection | Hepatitis C, Chronic

Spain
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

Hepatitis C

Spain
Digna Biotech S.L.

Completed

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Chronic Hepatitis C Virus Infection | Genotype 1 | Treatment-Experienced Patients | Relapses

Spain
Corporacion Parc Tauli
Hospital Mutua de Terrassa; Consorci Sanitari de Terrassa

Completed

Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study

Hepatitis B

Spain
Janssen R&D Ireland

Completed

A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Hepatitis C, Chronic

Spain, Germany, Poland
Hospital Mutua de Terrassa

Completed

Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study (MIC project)

Inflammatory Bowel Diseases | Hepatitis C Virus Infection

Spain
Valme University Hospital
Hospital Universitario de Canarias; Hospital Universitario Virgen Macarena; Hospital... and other collaborators

Unknown

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Hepatitis C, Chronic | Human Immunodeficiency Virus

Spain
Corporacion Parc Tauli
Germans Trias i Pujol Hospital; Hospital Universitario La Fe; Hospital Mutua... and other collaborators

Recruiting

Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

Hepatitis B

Spain
Bioaraba Health Research Institute

Not yet recruiting

Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)

Alcoholic Hepatitis

Spain
Instituto de Investigación Marqués de Valdecilla

Completed

Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) (PREVHEP)

Hepatitis B | Hepatitis C

Spain
Janssen R&D Ireland

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

Chronic Hepatitis C | Genotype 4 Chronic Hepatitis C

Spain
University of La Laguna

Completed

Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening

Hepatitis C Virus Infection

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

HIV Infections | Hepatitis C

Spain
Fundación Instituto de Estudios de Ciencias de...
Instituto de Investigación Biomédica de Salamanca; Spanish Clinical Research...

Completed

Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines

Hepatitis B | Hepatitis | Hepatitis, Viral, Human | Hepatitis B Immunization

Spain

Clinical Trials on Hepatitis D in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations